Prolonged-release fampridine and active motor training in MS patients: a Phase IV, double-blind, placebo-controlled

被引：0
|
作者：
Jacques, F. H. [1 ]
Nativ, A. [2 ]
Schembri, A. J. [3 ]
Paquette, C. [1 ]
Kalinowski, P. [3 ]
机构：
[1] Clin Neurooutaouais, Gatineau, PQ, Canada
[2] Clin Neurogym, Gatineau, PQ, Canada
[3] CogState, Melbourne, Vic, Australia
来源：
MULTIPLE SCLEROSIS JOURNAL | 2016年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1321
引用
收藏
页码：698 / 698
页数：1
相关论文
共 50 条
  • [41] DOUBLE-BLIND PLACEBO-CONTROLLED EXAMINATION OF TIMING EFFECTS IN THE TRAINING OF POSITIVE VERGENCES
    DAUM, K
    AMERICAN JOURNAL OF OPTOMETRY AND PHYSIOLOGICAL OPTICS, 1986, 63 (10): : 807 - 812
  • [42] NEUROFEEDBACK BALANCE TRAINING IN THE PREVENTION OF FALLS: A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Basta, D.
    Ernst, A.
    GERONTOLOGIST, 2013, 53 : 329 - 330
  • [43] Once Daily Controlled-Release Pregabalin In Fibromyalgia Patients: A Phase 3 Double-Blind, Randomized Withdrawal, Placebo-Controlled Study
    Arnold, Lesley M.
    Arsenault, Pierre
    Huffman, Cynthia
    Patrick, Jeffrey L.
    Messig, Michael
    Chew, Marci L.
    Sanin, Luis
    Pauer, Lynne
    Clair, Andrew
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1222 - S1222
  • [44] Randomised, Double-blind, Placebo-controlled Study of Iguratimod in the Treatment of Active Spondyloarthritis
    Li, Yan
    Li, Kunpeng
    Zhao, Zheng
    Wang, Yanyan
    Jin, Jingyu
    Zhang, Jianglin
    Zhu, Jian
    Huang, Feng
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3787 - 3788
  • [45] MINOCYCLINE IN ACTIVE RHEUMATOID-ARTHRITIS - A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    KLOPPENBURG, M
    BREEDVELD, FC
    TERWIEL, JP
    MALLEE, C
    DIJKMANS, BAC
    ARTHRITIS AND RHEUMATISM, 1994, 37 (05): : 629 - 636
  • [46] Randomised, Double-Blind, Placebo-Controlled Study of Iguratimod in the Treatment of Active Spondyloarthritis
    Li, Yan
    Li, Kunpeng
    Zhao, Zheng
    Wang, Yanyan
    Jin, Jingyu
    Guo, Junhua
    Zhang, Jie
    Zhang, Jianglin
    Zhu, Jian
    Huang, Feng
    FRONTIERS IN MEDICINE, 2021, 8
  • [47] Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging study
    Goodman, A. D.
    Cohen, J. A.
    Cross, A.
    Vollmer, T.
    Rizzo, M.
    Cohen, R.
    Marinucci, L.
    Blight, A. R.
    MULTIPLE SCLEROSIS, 2007, 13 (03): : 357 - 368
  • [48] Ondansetron in patients with tinnitus: randomized double-blind placebo-controlled study
    Taslimi, Shervin
    Vahidi, Hamed
    Pourvaziri, Ali
    Modabbernia, Amirhossein
    Fallah, Arezoo Yeke
    Yazdani, Nasrin
    Taslimi, Negin
    Hosseini, Mostafa
    Zarandi, Masoud Motesadi
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2013, 270 (05) : 1635 - 1641
  • [49] Apremilast for active ulcerative colitis: a phase 2, randomised, double-blind, placebo-controlled induction study
    Danese, S.
    Neurath, M.
    Kopon, A.
    Zakko, S.
    Simmons, T.
    Fogel, R.
    Maccarone, J.
    Zhan, X.
    Usiskin, K.
    Chitkara, D.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S4 - S5
  • [50] A pilot, double-blind, placebo-controlled trial of indinavir in patients with ALS
    Scelsa, SN
    MacGowan, DJL
    Mitsumoto, H
    Imperato, T
    LeValley, AJ
    Liu, MH
    DelBene, M
    Kim, MY
    NEUROLOGY, 2005, 64 (07) : 1298 - 1300
12345